The Autoset(R) autotitration system (Resmed, Australia) was designed as an
aid for determination of the effective level of CPAP. Two studies have show
n that the 95% pressure centile during a night with Autoset(R), after exclu
ding any periods with severe leak (P95), was well correlated with the press
ure determined manually according to the reference method. However, the sui
tability of P95 under Autoset(R) for treatment with conventional CPAP neede
d to be evaluated outside of the context of titration. The objective of thi
s study was to measure the compliance and efficacy of CPAP at P95 determine
d by Autoset(R), after 3 months. Twenty-four patients who had undergone rou
tine autotitration by Autoset(R) under polysomnographic control in the labo
ratory for previously untreated OSAS were evaluated after 3 months of treat
ment with CPAP at P95. This evaluation was based on compliance, daily usage
, determined by reading the hourly counter, Epworth sleepiness score and ho
me respiratory recording under CPAP. Polysomnography under Autoset(R) showe
d a significant reduction of abnormal respiratory events (apnea-hypopnea in
dex (AHI): 5.7 (+/-4.6) vs 69.6 (+/-29.8) n/h; p<0.001). P95 was between 8.
5 and 15 cm H2O (mean: 11.2 (+/-1.6)). Two patients were lost to followup.
At 3 months, 18 out of 22 (82%) patients declared that they were still usin
g their machine with a daily usage of 5.25 (+/-1.82) h. The Epworth sleepin
ess scale was significantly decreased (5 (+/-4.1) vs 11.4 (+/-5.4); p<0.05)
. P95 recommended by Autoset(R) remained effective on abnormal respiratory
events with a low AHI (4.1 (+/-3.2)n/h) and a low 4% oxygen desaturation in
dex (3.6 (+/-4.5) n/h) under CPAP.
This study confirms the efficacy of autotitration and the suitability of P9
5 determined by Autoset(R) for long-term treatment by conventional CPAP at
home.